This inventor holds 12 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: University of California. Active years: 2018-2025.
Company Filing History:
Years Active: 2018-2025
Title: Innovations by Adam R Sciambi
Introduction
Adam R Sciambi is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid sequencing. With a total of 12 patents to his name, Sciambi's work has advanced the methods used in biological analysis.
Latest Patents
One of his latest patents focuses on the sequencing of nucleic acids via barcoding in discrete entities. This patent describes microfluidic methods for barcoding nucleic acid target molecules, which can be analyzed using various nucleic acid sequencing techniques. The methods facilitate high-throughput sequencing of nucleic acid target molecules, as well as single cell and single virus genomic, transcriptomic, and proteomic analysis. Additionally, he has developed systems and devices that enable the practical application of these methods. Another notable patent involves methods for detecting biological components from samples. These methods can be used to detect and quantify specific components, such as circulating tumor cells, in biological samples.
Career Highlights
Adam R Sciambi is affiliated with the University of California, where he continues to innovate and contribute to research in biotechnology. His work has garnered attention for its potential applications in medical diagnostics and therapeutic development.
Collaborations
Some of his notable coworkers include Adam R Abate and Dennis Jay Eastburn, who have collaborated with him on various projects.
Conclusion
Adam R Sciambi's contributions to the field of biotechnology through his innovative patents have significantly impacted the methods of biological analysis. His work continues to pave the way for advancements in nucleic acid sequencing and detection methods.